Company Search:
Advanced Search
Sponsored Links
Eisai Company Limited - ADR Company Snapshot
Eisai Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other companies in this sector in the United States: Regeneron Pharmaceuticals Incorporated (2016 sales of $4.86 billion of which 100% was Research & Development), Endo International PLC ($4.01 billion of which 64% was Generics), and Zoetis Inc ($4.89 billion of which 50% was US).

Sales Analysis. Eisai Company Limited reported sales of $4.56 billion for the fiscal year ending March of 2016. This represents a decrease of 8.2% versus 2015, when the company's sales were $4.97 billion.
  Stock Performance Chart for Eisai Company Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 52.65
(Figures in U.S. Dollars)
1 Week 2.2%   13 Weeks -2.8%  
4 Weeks -6.8%   52 Weeks -20.9%  
Eisai Company Limited - ADR Key Data:
  Ticker: ESALY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,564,198,590
(Year Ending Jan 2017).
Employees: 9,877
  Currency: U.S. Dollars Market Cap: 15,061,858,859
  Fiscal Yr Ends: March Shares Outstanding: 286,075,192
  Share Type: Common Closely Held Shares: 23,311,079
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.